340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
After listening to the State of the Union address, Americans know why the latest Reuters poll has President Joe Biden at 41 percent approval.
Vice President Kamala Harris polls even lower – despite the obsequious efforts of the most biased media in history that has, in effect, merged with the Democratic Party.
The nation was reminded again why only 37% of Biden’s own party want him to run again.
Only a quarter of Americans believe the country is headed in the right direction under his leadership.
Given all that, what could a president possibly tell a nation when he entered office…
